FDA Inspection 1009089 — ALS Group USA Corp

ALS Group USA Corp — FEI 3012816064

The FDA completed an inspection of ALS Group USA Corp on February 6, 2017 in Houston, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 6, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Houston, TX (United States)

Citations

IDCFRDescription
197821 CFR 211.182Personnel dating/signing equipment log
441321 CFR 211.194(a)(8)Second person sign off